Acetylcholine (Ach) enhancement, useful in the treatment of Alzheimer's dis
ease (AD), may be obtained by means of ion channel modulators such as 4-ami
nopyridine (4-AP). 4-AP is also the central ring of tacrine, the first drug
approved for the treatment of AD. The synthesis and pharmacological activi
ty of three 4-AP derivatives, prepared with the aim of improving their anti
amnesic activity, is here described. In two of these compounds 4-AP is conn
ected to 4-aminobutyric acid (GABA), whereas in the third it is connected t
o 2-indolinone, i.e., the skeleton of linopirdine, another Ach enhancing ag
ent. The new compounds showed potent antiamnesic activity in comparison wit
h piracetam. (C) 2000 Edition scientifiques et medicales Elsevier SAS.